Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Malignant immunoproliferative disease, unspecified (C88.9)
C88.9
Malignant immunoproliferative disease, unspecified
Related indications (MeSH) (1)
Immunoproliferative Disorders20 drugs (10 approved, 10 experimental)
Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.